Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS)

10.1186/s12981-021-00402-7

Saved in:

Bibliographic Details
Main Authors:	Lim, Z. C., Hoo, G. S., Ang, J. H., Teng, C. B., Ang, L. W., Lee, C. C., Leo, Y. S., Law, H. L., Ng, O. T., Wong, C. S.
Other Authors:	PHARMACY
Format:	Article
Published:	BioMed Central Ltd 2022
Subjects:	Abacavir HIV Maintenance Rilpivirine Switch therapy Virologically suppressed
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/232699
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-232699
record_format	dspace
spelling	sg-nus-scholar.10635-2326992024-04-18T01:03:11Z Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS) Lim, Z. C. Hoo, G. S. Ang, J. H. Teng, C. B. Ang, L. W. Lee, C. C. Leo, Y. S. Law, H. L. Ng, O. T. Wong, C. S. PHARMACY MEDICINE SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH Abacavir HIV Maintenance Rilpivirine Switch therapy Virologically suppressed 10.1186/s12981-021-00402-7 AIDS Research and Therapy 18 1 80 2022-10-13T01:05:14Z 2022-10-13T01:05:14Z 2021-11-01 Article Lim, Z. C., Hoo, G. S., Ang, J. H., Teng, C. B., Ang, L. W., Lee, C. C., Leo, Y. S., Law, H. L., Ng, O. T., Wong, C. S. (2021-11-01). Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS). AIDS Research and Therapy 18 (1) : 80. ScholarBank@NUS Repository. https://doi.org/10.1186/s12981-021-00402-7 1742-6405 https://scholarbank.nus.edu.sg/handle/10635/232699 Attribution 4.0 International https://creativecommons.org/licenses/by/4.0/ BioMed Central Ltd Scopus OA2021
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Abacavir HIV Maintenance Rilpivirine Switch therapy Virologically suppressed
spellingShingle	Abacavir HIV Maintenance Rilpivirine Switch therapy Virologically suppressed Lim, Z. C. Hoo, G. S. Ang, J. H. Teng, C. B. Ang, L. W. Lee, C. C. Leo, Y. S. Law, H. L. Ng, O. T. Wong, C. S. Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS)
description	10.1186/s12981-021-00402-7
author2	PHARMACY
author_facet	PHARMACY Lim, Z. C. Hoo, G. S. Ang, J. H. Teng, C. B. Ang, L. W. Lee, C. C. Leo, Y. S. Law, H. L. Ng, O. T. Wong, C. S.
format	Article
author	Lim, Z. C. Hoo, G. S. Ang, J. H. Teng, C. B. Ang, L. W. Lee, C. C. Leo, Y. S. Law, H. L. Ng, O. T. Wong, C. S.
author_sort	Lim, Z. C.
title	Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS)
title_short	Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS)
title_full	Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS)
title_fullStr	Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS)
title_full_unstemmed	Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS)
title_sort	safety and effectiveness of switching to abacavir/lamivudine plus rilpivirine for maintenance therapy in virologically suppressed hiv-1 individuals in singapore (seals)
publisher	BioMed Central Ltd
publishDate	2022
url	https://scholarbank.nus.edu.sg/handle/10635/232699
_version_	1800915630582398976

Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS)

Similar Items